These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8357159)

  • 1. Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravis.
    Oger JJ
    Ann N Y Acad Sci; 1993 Jun; 681():110-2. PubMed ID: 8357159
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological heterogeneity and cellular mechanisms in myasthenia gravis.
    Newsom-Davis J; Willcox N; Schluep M; Harcourt G; Vincent A; Mossman S; Wray D; Burges J
    Ann N Y Acad Sci; 1987; 505():12-26. PubMed ID: 2825574
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases.
    Berrih-Aknin S; Morel E; Raimond F; Safar D; Gaud C; Binet JP; Levasseur P; Bach JF
    Ann N Y Acad Sci; 1987; 505():50-70. PubMed ID: 3318621
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro synthesis of IgG and antibodies to AChR by peripheral and thymic lymphocytes.
    Lisak RP; Levinson AI; Zweiman B; Kornstein MJ
    Ann N Y Acad Sci; 1987; 505():39-49. PubMed ID: 3500667
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of antibodies to neuronal α7-acetylcholine receptors in myasthenia.
    Lantzova VB; Sepp EK; Kozlovskii AS
    Bull Exp Biol Med; 2011 Jul; 151(3):305-7. PubMed ID: 22451872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the intrathymic pathogenesis of myasthenia gravis.
    Levinson AI
    J Neurol Sci; 2013 Oct; 333(1-2):60-7. PubMed ID: 23332143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody heterogeneity and specificity in myasthenia gravis.
    Vincent A; Whiting PJ; Schluep M; Heidenreich F; Lang B; Roberts A; Willcox N; Newsom-Davis J
    Ann N Y Acad Sci; 1987; 505():106-20. PubMed ID: 2446546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ; Lo YL
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies as probes for acetylcholine receptor epitopes in thymuses and thymic epithelial tumors of patients with myasthenia gravis and nonmyasthenic controls.
    Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
    Ann N Y Acad Sci; 1988; 540():508-10. PubMed ID: 2462825
    [No Abstract]   [Full Text] [Related]  

  • 11. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
    Schönbeck S; Chrestel S; Hohlfeld R
    Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia gravis, the acetylcholine receptor and the immune response.
    Barkas T
    Int J Immunopharmacol; 1979; 1(4):263-71. PubMed ID: 162144
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoantibodies in Myasthenia Gravis].
    Higuchi O
    Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine receptor antibody in myasthenia gravis.
    Marchiori PE; dos Reis M; Quevedo ME; Scaff M; Cossermelli W; Assis JL; de Oliveira RM
    Acta Neurol Scand; 1989 Nov; 80(5):387-9. PubMed ID: 2589004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: nicotinic acetylcholine receptors as targets for autoimmune attack.
    Newsom-Davis J; Harcourt G; Beeson D
    Biochem Soc Trans; 1989 Aug; 17(4):635-7. PubMed ID: 2670631
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymus, antibodies, and myasthenia.
    Keesey JC
    Neurology; 1992 Nov; 42(11):2227. PubMed ID: 1436550
    [No Abstract]   [Full Text] [Related]  

  • 17. Seronegative generalized myasthenia gravis: low frequency of thymic pathology.
    Verma PK; Oger JJ
    Neurology; 1992 Mar; 42(3 Pt 1):586-9. PubMed ID: 1296581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-acetylcholine receptor antibodies in myasthenia gravis: binding to membrane-bound Torpedo AChR.
    Koethe SM; DuPont BL; Calvo AM; Otterson G; McQuillen MP
    Ann N Y Acad Sci; 1987; 505():557-65. PubMed ID: 3479936
    [No Abstract]   [Full Text] [Related]  

  • 19. In myasthenia gravis cells from atrophic thymus secrete acetylcholine receptor antibodies.
    Katzberg HD; Aziz T; Oger J
    Neurology; 2001 Feb; 56(4):572-3. PubMed ID: 11222815
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood and thymic lymphocyte responses to peptide sequences of the acetylcholine receptor in myasthenia gravis.
    Harcourt G; Sommer N; Rothbard J; Beeson D; Willcox N; Newsom-Davis J
    Ann N Y Acad Sci; 1988; 540():354-6. PubMed ID: 2462811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.